Evaluation of Panbio rapid antigen test for SARS‐CoV‐2 in symptomatic patients and their contacts: a multicenter study

Evaluation of Panbio rapid antigen test for SARS‐CoV‐2 in symptomatic patients and their contacts: a multicenter study

Background: Point-of-care rapid tests to identify SARS-CoV-2 can have clinical benefits. Methods: A cross-sectional study in adults visiting emergency services or screening sites of referral hospitals for COVID-19 to validate the diagnostic performance of a rapid antigen test for SARS-CoV-2 (Abbott&...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ireri Thirion-Romero, Dr. Selene Guerrero-Zúñiga, Dr. Alexandra Arias-Mendoza, Dr. Dora Patricia Cornejo-Juárez, Dr. Patricia Meza-Meneses, Dr. Darwin Stalin Torres-Erazo, Dr. Thierry Hernández-Gilsoul, Dr. Arturo Galindo-Fraga, Dr. Isabel Villegas-Mota, Dr. Jesús Sepúlveda-Delgado, Dr. Santiago Ávila-Ríos, Dr. Eduardo Becerril-Vargas, Rosario Fernández-Plata, TIT Midori Pérez-Kawabe, Dr. Ana Coeto-Cano, Dr. Joel Armando Vázquez-Pérez, Dr. Simón Kawa-Karasik, Dr. Gustavo Reyes-Terán, Dr. José Rogelio Pérez-Padilla
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
COVID-19
SARS-CoV-2
point of care test
rapid antigen test
Panbio
Abbott
Infectious and parasitic diseases
RC109-216
Acceso en línea:https://doaj.org/article/36c9ec7fdecf47a98ba2299bde37eda2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares